Stock Screener App

Gratuito -

Installare

1.03

0.98% 0.01

Pre-mercato: 1.05 0.02 +1.94%

Humacyte Inc (HUMA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HUMA Giù? Forum Previsione

Humacyte Inc Borsa (HUMA) Ultime notizie

Dividend Watch: Does ASTE have strong fundamentalsJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn

Pharma News: What are the analyst revisions for Air T IncIs Humacyte Inc stock a good investment in YEAR2025 Short Interest & Community Verified Swing Trade Signals - baoquankhu1.vn

Smart Money: What is the target price for Humacyte Inc Equity Warrant stockRate Hike & Safe Entry Momentum Tips - baoquankhu1.vn

Rate Cut: What is the target price for Humacyte Inc Equity Warrant stockNew Guidance & Daily Growth Stock Tips - baoquankhu1.vn

Aug Swings: Whats the fair value of Humacyte Inc Equity Warrant stockJuly 2025 Volume & Daily Chart Pattern Signals - baoquankhu1.vn

Stop Loss: Will Humacyte Inc benefit from rising consumer demandRisk Management & Technical Confirmation Trade Alerts - baoquankhu1.vn

Humacyte, Inc. (NASDAQ:HUMA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Volatility Watch: What are Humacyte Incs technical support levelsTrade Analysis Summary & Community Supported Trade Ideas - baoquankhu1.vn

Humacyte (NASDAQ:HUMA) Given New $10.00 Price Target at Benchmark - MarketBeat

Benchmark lowers Humacyte stock price target to $10 on Israel filing plans - Investing.com India

Humacyte Stock (HUMA) Opinions on Recent Price Surge - Quiver Quantitative

Whale Trades: Whats the fair value of Humacyte Inc stock2025 Price Momentum & Daily Volume Surge Trade Alerts - baoquankhu1.vn

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 614% Upside in the Biotech Sector - DirectorsTalk Interviews

Published on: 2026-01-15 08:53:32 - baoquankhu1.vn

Analyst Upgrade: Can Humacyte Inc. stock maintain growth trajectoryTrade Signal Summary & Weekly Momentum Picks - Bộ Nội Vụ

CEO Moves: What catalysts could drive Humacyte Inc. stock higherPortfolio Risk Report & Fast Gain Stock Tips - Bộ Nội Vụ

Humacyte, Inc. (NASDAQ:HUMA): Are Analysts Optimistic? - Yahoo Finance

Quarterly Risk: Does Humacyte Inc Equity Warrant stock benefit from AI growthPortfolio Return Report & Verified Swing Trading Watchlists - baoquankhu1.vn

While institutions invested in Humacyte, Inc. (NASDAQ:HUMA) benefited from last week's 10% gain, retail investors stood to gain the most - simplywall.st

Wall Street analysts see Humacyte, Inc. (HUMA) as a buy: Should you invest? - MSN

Is Humacyte Inc. Equity Warrant stock undervalued vs historical averagesTrail vs Road Selection & quick comparison of popular models - ulpravda.ru

How buybacks impact Humacyte Inc. Equity Warrant stock valueJuly 2025 Gainers & Entry Point Confirmation Alerts - ulpravda.ru

Will Humacyte Inc. Equity Warrant stock gain from lower inflationPortfolio Gains Report & Fast Gaining Stock Reports - ulpravda.ru

Humacyte, Inc. (HUMA) Stock Analysis: Unveiling a Potential 571.55% Upside in the Biotech Sector - DirectorsTalk Interviews

Is Humacyte Inc. Equity Warrant stock a contrarian buyQuarterly Growth Report & Real-Time Volume Spike Alerts - ulpravda.ru

Will Humacyte Inc. stock recover faster than peersJuly 2025 Movers & Reliable Intraday Trade Alerts - ulpravda.ru

Can Humacyte Inc. Equity Warrant stock resist market sell offsOptions Play & Fast Gain Swing Trade Alerts - ulpravda.ru

Winners Losers: Can Humacyte Inc. stock deliver sustainable ROE2025 Sector Review & AI Enhanced Trading Alerts - ulpravda.ru

Form 8-KCurrent report - ADVFN

What sentiment indicators say about Humacyte Inc. stockMarket Sentiment Report & Weekly High Return Stock Opportunities - ulpravda.ru

Can Humacyte Inc. stock sustain revenue growthJuly 2025 Volume & Verified Chart Pattern Trade Signals - ulpravda.ru

How strong is Humacyte Inc. Equity Warrant stock revenue growthMarket Performance Report & Precise Buy Zone Identification - ulpravda.ru

Can Humacyte Inc. stock deliver sustainable ROEQuarterly Market Summary & AI Driven Stock Reports - ulpravda.ru

Today's Analyst Ratings: Humacyte (HUMA) Maintains "Buy" Rating - GuruFocus

Humacyte enters sales agreement with TD Securities - MSN

Preventable surgery complications can drive hospital charges toward $600K - Stock Titan

Patterns Watch: Can Humacyte Inc stock deliver sustainable ROESwing Trade & Risk Managed Investment Signals - moha.gov.vn

Humacyte, Inc.Common Stock (NQ: HUMA - FinancialContent

Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Humacyte rises on Symvess sale to military treatment facility - MSN

Humacyte jumps as DoD issues ECAT listing approval for Symvess - MSN

Humacyte Announces Planned Marketing Authorization Application for Symvess in Israel - marketscreener.com

Humacyte Inc announces planned marketing authorization application for Symvess in Israël - marketscreener.com

D. Boral Capital Reiterates "Buy" Rating for Humacyte (NASDAQ:HUMA) - MarketBeat

Humacyte plans to seek approval for vessel product in Israel By Investing.com - Investing.com Australia

Humacyte plans to seek approval for vessel product in Israel - Investing.com

Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel - The Manila Times

Humacyte, Inc. (HUMA) Stock Analysis: Exploring A Potential 718% Upside In Biotechnology - DirectorsTalk Interviews

Rate Hike: Is Humacyte Inc stock attractive for income investorsDollar Strength & Daily Entry Point Trade Alerts - moha.gov.vn

Humacyte, Inc. (NASDAQ:HUMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Why Is Humacyte, Inc. (HUMAW) Stock Down Today? - Meyka

Can Humacyte Inc. Equity Warrant stock maintain growth trajectoryChart Pattern Recognition & Compound Your Gains With Quality Stocks - Bollywood Helpline

Humacyte's (HUMA) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat

Humacyte Reports High Limb Salvage Rates and Durability of Symvess in Long-Term Study Published in JVS-CIT - Quiver Quantitative

RVMD

$99.82

2.09%

INCY

$103.47

0.87%

GMAB

$34.40

2.78%

BNTX

$119.34

1.14%

INSM

$162.64

1.83%

ONC

$336.16

0.48%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters